Brief: Bicycle Therapeutics To Present BT5528 Interim Phase I Data At AACR-NCI-EORTC Virtual International Conference On Molecular Targets And Cancer Therapeutics
30/09/2021 21:36
Sept 30 (Reuters) - Bicycle Therapeutics PLC BCYC.O :
* BICYCLE THERAPEUTICS TO PRESENT BT5528 INTERIM PHASE I
DATA AT
AACR-NCI-EORTC VIRTUAL INTERNATIONAL CONFERENCE ON MOLECULAR
TARGETS AND CANCER THERAPEUTICS
Source text for Eikon: ID:nBw9LKyW8a
Further company coverage: BCYC.O
Recent news on Bicycle Therapeutics
See all newsBicycle Therapeutics Q1 revenue drops after partnership terminations
Brief: Bicycle Therapeutics Announces Oral And Poster Presentations At The Aacr Annual Meeting 2026
UK's Bicycle Therapeutics Q4 revenue jumps, proposes 30% workforce reduction
Brief: Bicycle Therapeutics Says Travis Thompson Appointed As CFO, Succeeds Alethia Young
Bicycle Therapeutics Q3 net loss widens as R&D costs rise